HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

ruboxistaurin

inhibits protein kinase C beta; structure in first source
Also Known As:
13-((dimethylamino)methyl)-10,11,14,15-tetrahydro-4,9:16,21-dimetheno-1H,13H-dibenzo(e,k)pyrrolo(3,4-h)(1,4,13)oxadiazacyclohexadecene-1,3(2H)-dione; Arxxant; LY 333531; LY-333531; Lilly brand of ruboxistaurin mesilate hydrate; ruboxistaurin mesilate hydrate
Networked: 67 relevant articles (8 outcomes, 27 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Tuttle, Katherine R: 7 articles (04/2015 - 04/2005)
2. McGill, Janet B: 5 articles (04/2015 - 11/2005)
3. Anderson, Pamela W: 5 articles (04/2015 - 11/2005)
4. Sheetz, Matthew J: 5 articles (11/2011 - 12/2006)
5. Aiello, Lloyd Paul: 5 articles (11/2011 - 10/2005)
6. Kelly, Darren J: 5 articles (06/2009 - 08/2005)
7. Gilbert, Richard E: 5 articles (06/2009 - 08/2005)
8. Bastyr, Edward J: 4 articles (04/2015 - 08/2005)
9. Davis, Matthew D: 4 articles (11/2011 - 12/2006)
10. Zhang, Yuan: 4 articles (06/2009 - 08/2005)

Related Diseases

1. Diabetic Retinopathy (Retinopathy, Diabetic)
2. Macular Edema
3. Atherosclerosis
4. Low Vision (Subnormal Vision)
5. Proteinuria

Related Drugs and Biologics

1. protein kinase C beta
2. Protein Kinase C
3. Mesylates (Mesylate)
4. Apolipoproteins E (ApoE)
5. nephrin
6. NAD (NADH)
7. topiramate (Topamax)
8. Glucose (Dextrose)
9. Transforming Growth Factor beta (TGF-beta)
10. Citalopram (Escitalopram)

Related Therapies and Procedures

1. Lasers (Laser)
2. Oral Administration
3. Stents